Current Neuro-Oncology

Volume 16 Number 9
30 September 2014

Home > Publications > Current Neuro-Oncology > Volume 16, Year 2014 > Number 9, 30 September

Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, Vogelbaum MA.
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
J Neurosurg. 2014 Sep 5;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. PMID: 25192475. ˍ

Burzynski SR, Patil SS.
The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme.
J Cancer Ther. 2014 Sep 10;5(10):929-945∟. doi: 10.4236/jct.2014.510099∟. Laboratory investigation. ˍ

Burzynski SR, Janicki TJ, Burzynski GS.
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21).
J Cancer Ther. 2014 Sep 10;5(10):946-956∟. doi: 10.4236/jct.2014.510100∟. Interventional study. ˍ

Burzynski SR, Burzynski GS, Janicki TJ.
Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival.
J Cancer Ther. 2014 Sep 10;5(10):957-976∟. doi: 10.4236/jct.2014.510101∟. Case report. ˍ

Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A, Brookman S.
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22).
J Cancer Ther. 2014 Sep 10;5(10):977-988∟. doi: 10.4236/jct.2014.510102∟. Interventional study. ˍ